Genetic Analyzer Market, 2018
Global Genetic Analyzer
Market
Genetic analysis is a method of learning and
research in genetics and molecular
biology fields that involves use of wide group of applications while basic
system of the analysis is usually pertained to the orthodox genetics. Customary forms of analysis of genetic includes
the gene identification and inherited diseases analysis. Genetic analysis also
implicit the patients physical observation and the microscopic evaluation of
genetics as it is conducted for the long time. Genetic analysis is also applied
in differential diagnosis during the analysis of specific diseases, in mutation
detection, copy number changes in DNA.
Factors like
advancements in the technologies of genetic
testing, rise in prevalence of the genetic diseases, growing in the
awareness are boosting the genetic analyser market globally. Furthermore,
initiatives taken by the governments and increase in R&D investment and
activities in the genetic field are also driving the genetic analyzer market.
However, due to certain factors genetic analyzers use is restricted. The
operability of such kind of automated advanced machines requires technical
expertise leaving little room for human error. Calibration is essentially
needed for genetic analyzers. High cost of genetic analyzers resulting in their
availability in a limited number of research organizations is also hampering
the growth of the genetic analyzers
market globally.
Global genetic analyzer market is segmented on the basis of instruments, consumables,
application, end-user and geographical regions
Based on
product type, global genetic analyzer market is segmented as:
Instruments
DNA Microarrays
PCR
Next Generation
Sequencing
Serial Analysis of Gene
Expression
Northern Blotting
Consumables
DNA Chips
Reagents
Based on
the end-user, global genetic analyzer market is segmented as:
Diagnostics Centres
Drug Discovery
Research and Development
Others
Increase in the clinical
genome sequencing, increase in incidence of neurodegeneration diseases such as Alzheimers, Huntingtons and
Parkinsons disease and also cases of cancers prompts the interest in genetic
analysis. High swift in the acceptance of pediatric genetic testing used for of
screening adult onset disorders are the factors contributing to the genetic
analyzer market growth. Some of the government initiatives are improving the
healthcare delivery to different sections of population, mergers, acquisitions
and product launches of the companies are the factors driving the growth of the
genetic analyzer market.
Geographically, genetic
analyzer market is divided into Europe, Asia-Pacific North America, Latin
America, and Middle East and Africa. Global genetic analyser market is
dominated by North America due to the rise in diseases prevalence by genetic
disorders and rise in advancements technologically in the region. Asia-Pacific,
is expected to show significant growth during the forecast period in the
genetic testing market. India, China and Japan are expected as the fastest
growing genetic testing markets in the Asia-Pacific region due to increase in
R&D investment, a large pool of patients and rising government funding.
Some of the major
companies dealing in genetic testing market are Thermo Fisher Scientific Inc.
(U.S.), BioRad Laboratories (U.S.), Abbott laboratories (U.S.), AutoGenomics
Inc.( U.S.), Celera Group (U.S.), PerkinElmer Inc.( U.S.), Quest Diagnostics
Inc.( U.S.), ELITech Group (U.S.), Applied Biosystems Inc.( U.S.), F.
Hoffmann-La Roche AG (Switzerland), Transgenomic Inc.( U.S.).
In May 2017, Thermo
Fisher Scientific launched its Applied Biosystems SeqStudio Genetic Analyzer, a
new capillary electrophoresis system which can be used for plasmid sequencing,
species identification, human cell authentication and research in oncology
Related
Reports:
For
more business insights in Healthcare Industry:
Contact
Us:
+91-9987295242
Comments
Post a Comment